Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q33851158)
Watch
English
Interferons and bladder cancer
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
review article
1 reference
stated in
Europe PubMed Central
title
Interferons and bladder cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
author name string
Brown DH
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
Wagner TT
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
Bahnson RR
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
publication date
1 February 2000
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
published in
Urologic Clinics of North America
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
volume
27
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
page(s)
171-8, xi
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
issue
1
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
cites work
Effects of interferon in combination with cytotoxic drugs on mouse bladder tumor (MBT-2) growth in vitro and in vivo
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiproliferative Activities of Interferons Against Human Bladder Carcinoma Cell Lines in Vitro
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bacillus Calmette-Guérin potentiates monocyte responses to lipopolysaccharide-induced tumor necrosis factor and interleukin-1, but not interleukin-6 in bladder cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intralesional alpha interferon therapy in papillary superficial transitional cell carcinoma of the bladder. A pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacological biocompatibility between intravesical preparations of BCG and interferon-alpha 2B.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Enhancement of natural cytotoxicity in lymphocytes from animals with carcinogen-induced bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Chemoimmunotherapy for prophylaxis of recurrence in superficial bladder cancer: interferon-alpha 2b versus interferon-alpha 2b with epirubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of escalating doses of intravesical interferon alpha-2b in reducing recurrence rate and progression in superficial transitional cell carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized controlled study of intravesical alpha-2b-interferon in carcinoma in situ of the bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Conservative therapy for stage T1b, grade 3 transitional cell carcinoma of the bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy of murine bladder cancer with keyhole limpet hemocyanin (KLH).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cancer statistics, 1999.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravesical instillation of beta-interferon in the treatment of bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravesical treatment of bladder cancer with recombinant human interferon-beta. Intravesical GKT-beta Chemotherapy Research Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recombinant human interferon gamma exerts an anti-proliferative effect and modulates the expression of human leukocyte antigens A,B,C and DR in human urothelial cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current views on intravesical treatment and chemoprophylaxis of superficial bladder cancer. The present role of epirubicin and doxorubicin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Results at 43 months' follow-up of a double-blind, randomized, prospective clinical trial using intravesical interferon alpha-2b in the prophylaxis of stage pT1 transitional cell carcinoma of the bladder
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A controlled study of intravesical epirubicin with or without alpha 2b-interferon as prophylaxis for recurrent superficial transitional cell carcinoma of the bladder. Finnish Multicentre Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of fibronectin in intravesical BCG therapy for superficial bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunotherapy of murine transitional cell carcinoma of the bladder using alpha and gamma interferon in combination with other forms of immunotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination immunotherapy of murine transitional cell cancer using BCG and an interferon-inducing pyrimidinone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systemic IFN-alpha treatment of multiple bladder papilloma grade I or II patients: pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bacillus Calmette-Guérin plus intravesical interferon alpha-2b in patients with superficial bladder cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0094-0143%2805%2970245-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0094-0143(05)70245-7
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
Fatcat ID
release_wkg52nebzngrzof4yb3uqmtbgi
1 reference
stated in
Fatcat
reference URL
https://api.fatcat.wiki/v0/release/wkg52nebzngrzof4yb3uqmtbgi
retrieved
24 November 2022
based on heuristic
mapped directly with Wikidata item
PubMed ID
10696256
1 reference
stated in
Europe PubMed Central
PubMed ID
10696256
retrieved
29 July 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
